Home
>
National Drug Code (NDC)
>
Ranitidine
Ranitidine - 55289-505-14 - (Ranitidine)
Drug Information of Ranitidine
| Product NDC: | 55289-505 |
| Proprietary Name: | Ranitidine |
| Non Proprietary Name: | Ranitidine |
| Active Ingredient(s): | 300 mg/1 & nbsp; Ranitidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ranitidine
| Product NDC: | 55289-505 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075165 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091106 |
Package Information of Ranitidine
| Package NDC: | 55289-505-14 |
| Package Description: | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-505-14) |
NDC Information of Ranitidine
| NDC Code | 55289-505-14 |
| Proprietary Name | Ranitidine |
| Package Description | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-505-14) |
| Product NDC | 55289-505 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ranitidine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20091106 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
